GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Case-Control Study of Pancreas Cancer Etiologic Factors

$661,093
Yale University · R01 · FY2003 · CA

Optimizing anti-wild-type IDH1 therapy in pancreatic cancer

$661,060
Jordan M Winter · Case Western Reserve University · R01 · FY2025 · CA

Biological functions of chromosomal proteins

$660,935
Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Understanding efficacy and FE(II)-Promoted Activation of 1,2,4-Trioxolanes in cancer

$660,920
Eric Collisson · Fred Hutchinson Cancer Center · R01 · FY2025 · CA

Real-time MRI-guided adaptive radiotherapy of unresectable pancreatic cancer

$660,804
Ricardo Otazo · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA

Immune Enhancement and Therapy of Cancer

$660,725
Douglas Hanahan · University Of California, San Francisco · U01 · FY2006 · CA

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer

$660,703
Shounak Majumder · Mayo Clinic Rochester · U01 · FY2024 · CA

Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer

$660,603
John L Humm · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA

Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer

$660,603
John L Humm · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA

Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer

$660,603
John L Humm · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA

The BRCA Exchange Knowledgebase for Clinical Cancer Genetics

$660,079
Melissa Suzanne Cline · University Of California Santa Cruz · U24 · FY2025 · CA

Exposure and biological response biomarkers of cigarette smoke

$659,904
Ian Alexander Blair · University Of Pennsylvania · U01 · FY2007 · ES

Management and Data Coordination Unit for PCDC

$659,850
Ann Laura Oberg · Mayo Clinic Rochester · U24 · FY2025 · CA

Management and Data Coordination Unit for PCDC

$659,848
Ann Laura Oberg · Mayo Clinic Rochester · U24 · FY2022 · CA

FANCONI ANEMIA:GENOTYPE-PHENOTYPE CORRELATIONS

$659,752
Settara Chandrasekharappa · National Human Genome Research Institute · ZIA · FY2010 · HG

Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation

$659,516
Estuardo Aguilar-Cordova · Advantagene, Inc · R44 · FY2018 · CA

Addressing Chemoresistance in Pancreatic and Ovarian Cancers: Photodynamic Priming and Repurposing of Tetracyclines using Targeted Photo-Activable Multi-Inhibitor Liposome

$659,460
Huang Chiao Huang · Univ Of Maryland, College Park · R01 · FY2022 · CA

Isolation and Assessment of Blood-Circulating Cancer Exosomes with LSS and SERS Lab on a Chip Optical Spectroscopic Instrument

$659,419
Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA

Targeting Pancreatic Cancer

$659,264
Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA

Multifunctional Nanoparticles in Diagnosis and Therapy of Pancreatic Cancer

$659,110
Paras N. Prasad · State University Of New York At Buffalo · R01 · FY2009 · CA

Mutant KRAS targeted vaccines for the interception of pancreatic cancer development

$659,090
Neeha Zaidi · Johns Hopkins University · R37 · FY2025 · CA

Mutant KRAS targeted vaccines for the interception of pancreatic cancer development

$659,090
Neeha Zaidi · Johns Hopkins University · R37 · FY2024 · CA

Collagen Signaling in Pancreatic Cancer

$658,784
Howard C Crawford · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · CA

Exposure and biological response biomarkers of cigarette smoke

$658,708
Ian Alexander Blair · University Of Pennsylvania · U01 · FY2009 · ES

Integrating Epigenetic Modulation into DNA Damage Repair

$658,646
Pamela N Munster · University Of California, San Francisco · R01 · FY2025 · CA